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Abstract: Abstract Lacking compliance with liquid intake restrictions is one of the major problems in
patients on hemodialysis and causes an increased mortality. In 120 patients on hemodialysis with an
average interdialytic weight gain (IWG) exceeding 1.5 kg on at least 2 days during the 4 weeks preceding
the intervention, the effect of telemetric body weight measurement (TBWM) on IWG, ultrafiltration rate,
and blood pressure was evaluated over a period of 3 months. Patients of the telemetric group (TG) were
supplied with automatic scales, which transferred the weight via telemetry on a daily basis. In the case
of IWG of more than 0.75 kg/24 h, a telephonic contact was made as required, and in the case of an
IWG of more than 1.5 kg, telephonic contacting was obligatory along with the advice of a liquid intake
restriction to 0.5 L/day until the next dialysis. The patients of the control group (CG) received standard
treatment without telemetric monitoring. We examined specific data of the second interdialytic interval
(IDI2) and the average within 1 week. The average difference of IWG between TG and CG was not
significant before the start of the study but 0.2 kg (p=0.027) (IDI2)/0.27kg (p=0.001) (WP) at the end
of the study, respectively. The average difference in the ultrafiltration rate within 1 week was 19.0 mL/h
(p=0.282) (IDI2)/8.2 mL/h (p=0.409) before the start of the study but 28.4 mL/h (p=0.122) (IDI2)/30.9
mL/h (p=0.004) at the end of the study, respectively. Thus, TBWM is a feasible method for optimizing
the IWG and reducing the ultrafiltration rate.
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Abstract
Lacking compliance with liquid intake restrictions is one of the
major problems in patients on hemodialysis and causes an increased
mortality. In 120 patients on hemodialysis with an average inter-
dialytic weight gain (IWG) exceeding 1.5 kg on at least 2 days during
the 4 weeks preceding the intervention, the effect of telemetric body
weight measurement (TBWM) on IWG, ultrafiltration rate, and blood
pressure was evaluated over a period of 3 months. Patients of the
telemetric group (TG) were supplied with automatic scales, which
transferred the weight via telemetry on a daily basis. In the case of
IWG of more than 0.75 kg/24 h, a telephonic contact was made as
required, and in the case of an IWG of more than 1.5 kg, telephonic
contacting was obligatory along with the advice of a liquid intake
restriction to 0.5 L/day until the next dialysis. The patients of the
control group (CG) received standard treatment without telemetric
monitoring. We examined specific data of the second interdialytic
interval (IDI2) and the average within 1 week. The average difference
of IWG between TG and CG was not significant before the start of
the study but 0.2 kg (p =0.027) (IDI2)/0.27kg (p = 0.001) (WP)
at the end of the study, respectively. The average difference in the
ultrafiltration rate within 1 week was 19.0mL/h (p= 0.282) (IDI2)/
8.2mL/h (p =0.409) before the start of the study but 28.4mL/h
(p =0.122) (IDI2)/30.9mL/h (p= 0.004) at the end of the study,
respectively. Thus, TBWM is a feasible method for optimizing the
IWG and reducing the ultrafiltration rate.
Key words: telemedicine, telemetry, diagnostic techniques and
procedures, patient compliance, hemodialysis, interdialytic weight
gain, body weight, blood pressure, fluid intake
Introduction
P
atients with end-stage renal failure on hemodialysis fre-
quently suffer from a compelling sensation of thirst.
Therefore the desired liquid intake due to the reduced pa-
tient’s urine production is often exceeded. More than 74% of
patients in hemodialysis have difficulties with their liquid intake
restriction.1,2 Elevated liquid intake correlates with an increased in-
terdialytic weight gain (IWG) in the form of hypervolemia.2 The in-
creased weight gain can be seen as an indicator for nonadherence to
the liquid intake restrictions.3 Poor liquid intake compliance has a
negative effect on the long-term survival in patients on hemodial-
ysis.4 There is a correlation between an increased IWG and an in-
creased mortality, which was shown in large studies.5,6 It was also
shown that there is a 35% increased death risk due to weight gain.
Furthermore, increased IWG results in the need for higher ultrafil-
tration rates (UFRs).
Patients having UFRs over 12.37mL/h/kg of body weight have an
increased mortality.7 The long-term prognosis related to acute
myocardial infarction and coronary heart disease is also impaired by
high UFRs.8 The noncompliance with liquid intake restrictions is a
considerable risk factor for acute hospitalization due to hypervole-
mia (for example, pulmonary edema, hypertensive crisis, and myo-
cardial infarction).9
It is also a risk for cardiac long-term damage (diastolic and systolic
heart failure, left ventricular hypertrophy)10–13 and dialysis-associated
events such as a mortality-increasing hypotension,14–16 muscle
cramps,17,18 and ischemic complications because of the required high
filtration rates. Furthermore, 60–90% of dialysis patients suffer from
hypertension, in particular, systolic hypertension,14 which is often not
adequately controlled with antihypertensive medication. In this situ-
ation, a consequent reduction of the daily liquid intake is re-
commended19 to achieve an appropriate blood pressure decrease.20
End-organ damage caused by recurrent hypervolemia and high
blood pressure undulation under hemodialysis increases the already
elevated morbidity and mortality.15,21 The current approaches to
assist liquid intake compliance are not able to solve the issues ob-
served in the daily routine of nephrology practice.22,23 The applica-
tion of telemetric transmission of self-measured body weight via
modern telecommunication technology and information technology
between physician and patient is a new indication. We hypothesize
that telemetric body weight measurement (TBWM) can improve
compliance and thus reduce morbidity and mortality in patients
under hemodialyses.
Preliminary results from this study have been presented previously
in abstract form.24–28
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Patients and Methods
PATIENTS AND STUDY DESIGN
After consent of the local ethics committee at the Georg-August-
University Go¨ttingen (Go¨ttingen, Germany) and education and
written consent of the patients, 120 patients with end-stage renal
failure requiring hemodialysis (>6 months, three times a week) and
who experienced an average weight gain of at least 1.5 kg during the
2-day interval between the second and third dialysis in the course of
the week (second interdialytic interval [IDI2]) within the last 4 weeks
before inclusion in the study were randomized in two groups in this
monocentric (Center of Nephrology Go¨ttingen), prospective, open
body weight telemetry study (Table 1).
Both groups received standard care including body weight mea-
surement directly before and after dialysis treatment in the dialysis
center (EDI-63; Waegetechnik Kohn Ltd., Siegen, Germany) (scales
accurate to 0.1 kg). The telemetry group (TG) was additionally sup-
plied with telemetric weight monitoring. Patients were instructed to
weigh their body weight under possibly equal terms daily before and
after dialysis and once daily on days without dialysis at a time cor-
responding to the start of the dialysis. The observation period was 3
months for each patient.
The dialyses were carried out with a Nikkiso DBB 05 hemodialysis
machine (Nikkiso Medical Ltd., Tokyo, Japan) in combination with a
kidney low-flux dialyzer (FX 8; Fresenius Medical Care AG & Co.
KGaA, Bad Homburg, Germany). Blood pressure measurements were
carried out with a Stabil-O-Graph (IEM Ltd., Stolberg, Germany).
TBWM
Patients of the TG were supplied with TC 100 Mobil (IEM Ltd.)
scales. The scales offer an accuracy of measurement of 0.1 kg. The
mean deviation is – 0.2 kg with a standard deviation of 0.06 kg. The
scales are equipped with a Bluetooth (Bluetooth SIG, Kirkland, WA)
interface for data transmission to Bluetooth-compatible mobile
phones, which were handed to the patients. Once a patient carried out
a successful measurement with the TC 100 Mobil scale, data trans-
mission was initiated automatically (Fig. 1).
ALARM ALGORITHMS
In the case of a weight gain of more than 0.75 kg between two
measurements, an alarm report was sent to the physician by e-mail.
The weight gain was then discussed at the next dialysis appointment
or on the telephone. An alarm report was generated once a day at
most. If measurement was missed for more than 3 days, a warning of
underusage was sent to the physician. Furthermore, a monthly re-
port and a weekly report of the patient’s weight parameters were
generated. The status reports were handed to the patients during
Table 1. Patient Population After Randomization in the






Number of patients (M:F) 60 (30:30) 60 (31:29)





Age (years) 65.7– 14.7 66.5– 13.8 0.721
Height (cm) 166.9– 7.9 165.5 – 9.6 0.789
Weight (kg) 76.1– 15.7 74.6– 17.4 0.699
BMI (kg/m2) 27.3– 5.5 27.5– 6.5 0.759
Requiring dialysis (months) 27.2– 18.9 25.6– 14.7 0.692
Duration of dialysis (h) 4.56– 0.7 4.58– 0.9 0.741
Hemoglobin (g/dL) 11.8– 1.4 12.1– 1.8 0.231
Serum urea (mg/dL) 128.2– 3.9 128.7 – 41.3 0.561
Uric acid (mg/dL) 8.4– 3.8 7.5– 3.1 0.199
Phosphate (mmol/L) 1.9– 0.6 1.8– 0.8 0.226
Potassium (mmol/L) 5.3– 1.2 5.4– 1.1 0.564
Data are number of patients or mean– standard deviation values as indicated.
BMI, body mass index; D, two dialysis sessions a week; F, femaleM, male; MI,
methodological noncompliance.
Fig. 1. Concept of data management. (1) The patient’s weight is
sent from the scale via Bluetooth to a mobile phone, (2) which
sends the encrypted blood pressure data via short message ser-
vice to the remote operating system (ROS). (3) The ROS decrypts
the data and transfers them to the central data bank. (4) If the
weight is beyond the alarm limit, an alarm is generated, which is
sent as e-mail from the ROS to the physician, (5) who can, in the
case of an alarm, contact the patient and ask about liquid intake
compliance and the state of his or her health. Moreover, further
procedures can be discussed. (6) At any time the physician is able
to access all data in the database via a Web interface.
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dialysis, and the results were discussed. If a weight
gain exceeded 1.5 kg between two measurements, an
intervention via phone was mandatory. For a weight
gain between 0.75 kg and 1.5 kg, an individual de-
cision on intervening was made depending on the
patient’s profile and the other interdialytic weight
changes.
STUDY END POINTS
Primary study end points were the IWG during the
IDI2 per week and the average ultrafiltration. Sec-
ondary end points were blood pressure characteristics
during dialysis.
In order to monitor the course of a patient’s weight
gain between the dialyses, the weight change between
the second and third dialysis in the course of the week,
subsequently termed IDI2, was analyzed separately.
Furthermore, the unfiltered data obtained between
any two dialyses were analyzed as well. For the IDI2 the
last four dialyses were used; for the unfiltered data the
last 12 dialyses were used. Four datasets measured in
the IDI2 and 12 unfiltered data sets correspond to
measurement over 4 weeks, respectively. This makes it
easier to compare with data obtained in the 4-week
period preceding the study.
STATISTICAL ANALYSIS
All of the statistical analyses were performed using SPSS software
(SPSS for Windows version 11.5.1; SPSS Inc, Chicago, IL). The data
were analyzed using t tests for independent samples. Homogeneity of
variances was checked using Levene’s test. The normal distribution
assumption was analyzed via the Shapiro–Wilk test as
well as the Kolmogorov–Smirnov test, using the
correction of the significances by Lilliefors.
Results
INTERDIALYTIC WEIGHT GAIN
During the study the IWG (IDI2) was reduced
from 2.22 – 0.84 kg to 2.11 – 0.84 kg in the TG
(p = 0.474), whereas in the control group (CG) a
small rise from 2.29 – 1.08 kg to 2.33 – 1.08 kg
(p = 0.839) was observed. The unfiltered data show a
reduction of the weight gain from 2.41 – 1.01 kg to
2.31 – 0.94 kg in the TG (p = 0.575) and a weight
gain from 2.53 – 1.32 kg to 2.58 – 1.25 kg in the
CG (p = 0.831) (Figs. 2 and 3). The mean difference
in weight gain between the groups was 0.07 kg
(p = 0.198) for the IDI2 at the beginning of the study
and 0.22 kg (p = 0.027) at the end of the study. The
mean difference in weight gain for the unfiltered
weekly data was 0.12 kg (p = 0.072) at the beginning
of the study and 0.27 kg (p < 0.001) at the end of the
study.
ULTRAFILTRATION
At the end of the IDI2 the UFR was reduced from 604.6–148.3mL/h
to 593.7–156.5mL/h in the TG (p=0.696) and from 623.6–185.8mL/h
to 622.07 – 196.1mL/h in the CG (p = 0.965). Over the whole
week the average UFR was reduced from 631.1 – 170.6mL/h to
621.6 – 169.7mL/h in the TG (p = 0.760) and was increased from
639.2 – 195.5mL/h to 652.5 – 198.6mL/h in the CG (p = 0.712). The
mean difference between the TG and CG values for the IDI2 was
Fig. 2. Interdialytic weight gain at the end point (only the second interdialytic
interval [IDI2]). TBWM, telemetric body weight measurement.
Fig. 3. Interdialytic weight gain at the end point (unfiltered). TBWM, telemetric body
weight measurement.
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19.0mL/h (p = 0.282) before the start of the study and 28.4mL/h
(p = 0.122) at the end of the study. The mean weekly difference was
8.2mL/h (p = 0.409) prior to the study’s start and 30.9mL/h
(p = 0.004) at the end of the study (Fig. 4).
MEAN TIME DURATION ON DIALYSIS
At baseline the mean time on dialysis was 4.56 – 0.79 h in the TG
and 4.58 – 0.99 h in the CG (p = 0.74). At the end of the study the
average time on dialysis was 4.47 – 0.75 h in the TG and 4.62 – 0.87 h
in the CG (p = 0.001) (Fig. 5).
BLOOD PRESSURE
In the TG there was, compared with the CG, a sig-
nificant higher diastolic blood pressure and a lower
systolic blood pressure by trend. At the end of the
study this difference was present at the start and the
end of a dialysis session (Table 2).
TELEMETRIC BODY WEIGHT DATA
During the study a reduction of the average daily
weight gain from 831 – 323 g/day in the first week to
707 – 339 g/day in the last week of the study
(p = 0.098) in a persistent manner (Fig. 6) could be
observed in the TG. The median weight gain was re-
duced from 814 g/day to 727 g/day.
Discussion
The current study demonstrated that a reduction of
the IWG can be achieved by telemetric monitoring of
the body weight. This is important especially with
regard to the correlation of a high IWG and an in-
creased mortality.5,6
At the end of the study TG patients were dialyzedwith
a significantly lower UFR compared with CG patients.
To summarize, initially there was no significant difference in both
groups regarding all analyzed parameters. The intergroup statistics did
not show any significant change over the study period, but parameters
directly dependent on fluid intake such as IWG, ultrafiltration, and
duration of dialysis were persistentlymodified in the opposite direction
within both groups over the whole investigation time, resulting in
significant differences at the end of the study between the two groups.
This is consistent with the normal course of patients on hemodialysis,
which means that these patients sustain a reduction of
diuresis because of their kidney disease. Without ef-
fectively restricting fluid intake these changes are
connected with a slow but ongoing increase of IWG.
The failing statistical significance within the TG in
spite of the obvious trend may be explained by a
naturally occurring large individual variance of IWG
in patients on hemodialysis. For example, IWG is of
less clinical relevance for a patient weighing 90 kg
than for one weighing 60 kg. Furthermore, even the
same patient may exhibit a large variance in IWG
between 1 and 5 kg. Using TBWM, a lower UFR and a
significant reduction of mean time duration on dia-
lysis are achieved because an increased uptake of
liquid intake can be avoided. The above-mentioned
consideration is relevant in the context of a high UFR
leading to increased mortality7,8 and playing an im-
portant role in pathophysiology of hypotensive crises
during dialyses.16 Furthermore, high UFR accounts
for a poorly adjustable blood pressure because of a
reactive release of aldosterone.29
Fig. 4. Ultrafiltration at the end point (unfiltered). TBWM, telemetric body weight
measurement.
Fig. 5. Mean time duration on dialysis. TBWM, telemetric body weight
measurement.
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Hemodynamics during dialysis were not the primary focus of this
study considering that blood pressure during hemodialysis provides
only small prognostic value for these patients and depends on many
different factors such as calcium and sodium concentration, left
ventricular function, and antihypertensive medication. Thus, using
TBWM a significantly higher diastolic and by trend a lower systolic
blood pressure are achieved. Low diastolic blood pressure rates result
in increased mortality in dialysis patients30,31 so that an increase in
this parameter might reflect a positive effect.20,32 The decrease of the
systolic blood pressure is desirable in the context of hypertension and
cardiovascular diseases,33,34 resulting in decreased mortality.35
Moreover, a decrease of the pulse pressure during dialysis was
achieved in the experimental group. A direct association between a
high pulse pressure and a higher cardiovascular risk was found in
multiple studies.36–38 Furthermore, it has a better correlation to end-
organ damage and cardiovascular diseases than brachial blood
pressure office readings.39–42 A direct relation between mortality rate
and pulse pressure has been reported: an increase in pulse pressure of
10mm Hg is associated with a 12% increase in mortality.43 In sum-
mary, all blood pressure results based on blood pressure measure-
ment during dialysis have to be judged with caution.
We believe that combination of TBWM with 24-h pulse wave
analysis (PWA) via upper arm cuff of a special ABPMdevice, e.g., PWA
monitor Mobil-O-Graph (IEM Ltd., Stolberg, Germany),44 allows direct
recording of the influence of a reduced IWG gain on augmentation
index, cardiac output, and notably the 24-h blood pressure charac-
teristics.45 In particular, the effects of a reduced IWG on blood pressure
should be examined via 24-h or 48-h blood pressure measurement in
order to obtain a more exact evaluation of blood pressure character-
istics46 and to interpret possible differences in the survival rate.47
Combined with regular medical and custodial
care, TBWM is a feasible method to optimize the
IWG and to reducte UFR at dialysis. Interven-
tions by phone and instruction during dialyses
can be planned easily. The individual weight-
dependent liquid intake adjustment considers
varying external parameters such as tempera-
ture and air humidity and physical exercise,
as well as special metabolism situations (e.g.,
diarrhea).
Moreover, by reduction of the weight variability
using the telemetry technique, a significant in-
fluence on blood pressure characteristics is
achieved. To evaluate possible positive effects on
undesirable events like blood pressure crises,
vascular events, hospitalization rates, and mor-
tality rate, a larger organized study with the co-
operation of several locations during a longer time
of evaluation appears advisable.
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Table 2. Blood Pressure
BLOOD PRESSURE (MM HG)
BEFORE BEGINNING
OF STUDY END OF STUDY
TG CG TG CG
At the beginning of dialysis
IDI2
Systolic 117.0– 18.9 116.9 – 16.9 116.0 – 17.0 117.9– 19.5
Diastolic 66.8– 10.2 67.0– 9.0 66.9– 8.7a 65.0– 8.8a
Unfiltered
Systolic 118.3– 19.8 117.1 – 17.4 117.7 – 17.9 119.6– 18.9
Diastolic 67.5– 9.7 67.0– 9.5 67.8– 9.3a 66.4– 9.3a
At the end of dialysis
IDI2
Systolic 114.0– 17.1 113.1 – 18.4 111.5 – 14.3 110.7– 18.2
Diastolic 65.1– 8.4 64.1– 6.8 65.2– 7.1 64.6– 8.1
Unfiltered
Systolic 113.4– 16.2a 111.7 – 17.3a 112.7 – 15.0 111.4– 17.2
Diastolic 65.2– 7.9 64.4– 7.3 65.6– 7.8a 64.0– 7.7a
Data are mean– standard deviation values.
ap < 0.05.
CG, control group; IDI2, second interdialytic interval; TG, telemetry group.
Fig. 6. Interdialytic weight gain progression seen in telemetrically transmitted data.
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